title: Nonalcoholic fatty liver disease and metabolic syndrome: a concise review.
abstract: Non-alcoholic fatty liver disease (NAFLD) is a clinicopathological entity increasingly recognized as a major health burden in developed countries. In the last decade, several studies have independently provided evidence for a strong association between NAFLD and each component of the metabolic syndrome, including central obesity, hyperglycemia, dyslipidemia, and hypertension. This article focuses on epidemiological, clinical, pathogenic and therapeutic aspects, which link these two syndromes.
authors.affiliation: Department of Internal Medicine 1, Filantropia University Hospital of Craiova, University of Medicine and Pharmacy of Craiova, Romania. letitiastreba@yahoo.com
authors.forename: Letiţia Adela Maria
authors.initials: LA
authors.lastname: Streba
authors.forename: Doina
authors.initials: D
authors.lastname: Cârstea
authors.forename: P
authors.initials: P
authors.lastname: Mitruţ
authors.forename: C C
authors.initials: CC
authors.lastname: Vere
authors.forename: Nicoleta
authors.initials: N
authors.lastname: Dragomir
authors.forename: C T
authors.initials: CT
authors.lastname: Streba
mesh_terms: D000273:Adipose Tissue / Q000502:physiology; D003210:Concept Formation; D005234:Fatty Liver / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000209:etiology*; D018384:Oxidative Stress / Q000502:physiology